TrialScientific reports2019

Randomized Evaluation of Anagliptin vs Sitagliptin On low-density lipoproteiN cholesterol in diabetes (REASON) Trial: A 52-week, open-label, randomized clinical trial.

Takeshi Morimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.